Sign inJoin waitlistJoin the waitlist

Alexander Z. Wei

Associate Program Director, Hematology & Oncology Fellowship Program · Columbia University Irving Medical Center

Credentials: · ·

History

Hematology & Oncology Fellowship · Columbia University Irving Medical Center
Present
Columbia University Irving Medical Center
Present

Columbia University Irving Medical Center
Columbia University Irving Medical Center
Columbia University Irving Medical Center
John A. Burns School of Medicine at the University of Hawaii
University of Rochester

Research

Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19
Cells · 2021 · 46 citations
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations
British Journal of Cancer · 2022 · 27 citations
Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
Review · Therapeutic Advances in Medical Oncology · 2023 · 19 citations

RC
Richard Carvajal
6 papers
Karie Runcie
5 papers
Mark Stein
5 papers
AS
Alexander Shoushtari
4 papers
AM
Ashray Maniar
3 papers · 3 as a fellow
David Roh
3 papers
Imo Akpan
3 papers
Jacob Valk
3 papers · 3 as a resident
JZ
James Zimring
3 papers
Kenichi Tanaka
3 papers
Richard Francis
3 papers
Stacie Kahn
3 papers · 3 as a fellow

Clinical trials

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
Principal investigator · Recruiting · Phase 2
Columbia University
2025–2028
Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Principal investigator · Terminated · Phase 2
Columbia University
2022–2023
APX005M and Doxorubicin in Advanced Sarcoma
Principal investigator · Completed · Phase 2
Alexander Z. Wei, MD
2019–2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033